These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 22425063)
1. Objective reduction in adenoid tissue after mometasone furoate treatment. Rezende RM; Silveira F; Barbosa AP; Menezes UP; Ferriani VP; Rezende PH; Anselmo-Lima WT; Valera FC Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):829-31. PubMed ID: 22425063 [TBL] [Abstract][Full Text] [Related]
2. Does atopy influence the effectiveness of treatment of adenoid hypertrophy with mometasone furoate? Rezende RM; Amato FS; Barbosa AP; Menezes UP; Rezende P; Ferriani VP; Anselmo-Lima WT; Valera FC Am J Rhinol Allergy; 2015; 29(1):54-6. PubMed ID: 25590321 [TBL] [Abstract][Full Text] [Related]
3. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Berlucchi M; Salsi D; Valetti L; Parrinello G; Nicolai P Pediatrics; 2007 Jun; 119(6):e1392-7. PubMed ID: 17533178 [TBL] [Abstract][Full Text] [Related]
4. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children]. Liu W; Chen RJ Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263 [No Abstract] [Full Text] [Related]
5. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732 [TBL] [Abstract][Full Text] [Related]
6. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Cengel S; Akyol MU Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):639-45. PubMed ID: 16169093 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. Berlucchi M; Valetti L; Parrinello G; Nicolai P Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1171-5. PubMed ID: 18499270 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Tuhanıoğlu B; Erkan SO Turk J Med Sci; 2017 Dec; 47(6):1736-1743. PubMed ID: 29306232 [TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Zeng M; Long XB; Cui YH; Liu Z Am J Rhinol Allergy; 2011; 25(6):e203-7. PubMed ID: 22185725 [TBL] [Abstract][Full Text] [Related]
11. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children. Bhargava R; Chakravarti A J Laryngol Otol; 2014 Dec; 128(12):1060-6. PubMed ID: 25404102 [TBL] [Abstract][Full Text] [Related]
12. The role of mometasone furoate nasal spray in the treatment of adenoidal hypertrophy in the adolescents: a prospective, randomized, cross-over study. Yilmaz HB; Celebi S; Sahin-Yilmaz A; Oysu C Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2657-61. PubMed ID: 23381494 [TBL] [Abstract][Full Text] [Related]
13. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work? Chadha NK; Zhang L; Mendoza-Sassi RA; César JA Otolaryngol Head Neck Surg; 2009 Feb; 140(2):139-47. PubMed ID: 19201278 [TBL] [Abstract][Full Text] [Related]
14. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age]. Berlucchi M; Tomenzoli D Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575 [TBL] [Abstract][Full Text] [Related]
15. Exploring the characteristics of children with obstructive adenoid responding to mometasone fuorate monohydrate: preliminary results. Bitar MA; Mahfoud L; Nassar J; Dana R Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):931-7. PubMed ID: 23010795 [TBL] [Abstract][Full Text] [Related]
16. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy. Ras AE; Hamed MH; Abdelalim AA Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830 [TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis. Bernstein DI; Teper A; Gopalan G; Gates D Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of nasal corticosteroid in preventing regrowth after adenoidectomy. Yildirim YS; Senturk E; Eren SB; Dogan R; Tugrul S; Ozturan O Auris Nasus Larynx; 2016 Dec; 43(6):637-40. PubMed ID: 27036360 [TBL] [Abstract][Full Text] [Related]
19. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Gawchik S; Goldstein S; Prenner B; John A Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964 [TBL] [Abstract][Full Text] [Related]
20. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]